[][com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90365]], camposKey:1367-0484 2025-10-01 Diagnostic age- and sex-adjusted reference intervals of Meibomian gland morphological features00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89509]], camposKey:2077-0383 2025-08-01 Clinical Characterization of the Lacrimal Functional Unit in Patients with Chronic Ocular Pain Associated with Dry Eye Disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89510]], camposKey:0002-9394 2025-08-01 Corneal Sensory Changes and Nerve Plexus Abnormalities in Chronic Neuropathic Ocular Pain and Dry Eye Postrefractive Surgery170185, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=96298]], camposKey:2077-0383 2025-07-01 Long-Term Evolution of Chronic Neuropathic Ocular Pain and Dry Eye Following Corneal Refractive Surgery00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89802]], camposKey:1661-6596 2025-01-01 Long-Term Clinical and Molecular Changes in Dry Eye Disease and Chronic Ocular Pain00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=90370]], camposKey:2193-8245 2024-05-01 Short-Term Efficacy of Ophthalmic Cyclosporine: A 0.1% Cationic Emulsion in Dry Eye Patients Assessed Under Controlled Environment11971210, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89116]], camposKey:0014-4835 2024-01-01 Analysis of the mucosal chemokines CCL28, CXCL14, and CXCL17 in dry eye disease: An in vitro and clinical investigation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=81857]], camposKey:1542-0124 2024-01-01 Gene expression changes in conjunctival cells associated with contact lens wear and discomfort3142, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89248]], camposKey:0927-3948 2024-01-01 Tear Cytokines as Predictive Biomarkers of Success in Contact Lens Discomfort Management23392347, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72870]], camposKey:2045-2322 2022-10-06 Effect of a single vectored thermal pulsation treatment of Meibomian gland dysfunction patients under controlled environmental conditions00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72871]], camposKey:0014-4835 2022-06-01 Inflammation-related molecules in tears of patients with chronic ocular pain and dry eye disease00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=73184]], camposKey:1139-7632 2022-01-01 Detección precoz de la ambliopía en Atención Primaria00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=75252]], camposKey:1139-7632 2022-01-01 Early detection of amblyopia in Primary Health Care Detección precoz de la ambliopía en Atención Primaria7584, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=89299]], camposKey:0146-0404 2022-01-01 Evaluation of gene expression in conjunctival epithelial cells associated with contact lens wear and discomfort00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=72872]], camposKey:1367-0484 2022-01-01 Is contact lens discomfort related to meibomian gland morphology?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65276]], camposKey:1367-0484 2021-12-01 Usefulness of a global rating change scale for contact lens discomfort evaluation00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=65277]], camposKey:1367-0484 2021-08-01 Does placebo effect exist in contact lens discomfort management?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=66297]], camposKey:1542-2321 2021-05-01 Contact Lens Discomfort Management: Outcomes of Common Interventions256264, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=59742]], camposKey:2193-8245 2020-01-01 Therapeutic Instruments Targeting Meibomian Gland Dysfunction797807, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53217]], camposKey:1367-0484 2019-01-01 Analysis of the placebo effect in comfort during contact lens wear00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=53363]], camposKey:1367-0484 2019-01-01 Is contact lens discomfort related to the morphology and function of the Meibomian glands?00, com.sigma.fs3.argos.domain.gpc.GpcArticlesRev[id=com.sigma.fs3.argos.domain.gpc.GpcArticlesRevPK[ifcactivitat=ARE, ifccomptador=39843]], camposKey:1367-0484 2018-01-01 A new method to analyse the effect of multifocal contact lenses on visual function169174][][][][][][][][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63261]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62189]]][com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=63261]], com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBeca[id=com.sigma.fs3.argos.domain.gpc.GpcAltresAjutsBecaPK[ifcactivitat=AAB, ifccomptador=62189]]][][][][][][][][][][][com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@31503619, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@7d6d49e9, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@17159add, com.sigma.investigacion.cawdos.utilidades.CongresoYSusAsociaciones@41f06d79][][com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@3e6951, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@6945b5, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@694a4d, com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ConvenisPPC@694990][][][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=61608]]][com.sigma.fs3.argos.domain.gpc.EstadesFora[id=com.sigma.fs3.argos.domain.commons.ArgosPK[act=ESF, cont=61608]]][][][][com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c73fd], com.sigma.investigacion.cawdos.entities.ayudaInvestigacion.ProjectesPPC[id=com.sigma.fs3.argos.domain.gpc.ayudasrecerca.ProjectesPPCId@5c73a5]][][][][][][][com.sigma.fs3.argos.domain.gpc.altres.ProjecteInnovacio@1561c][]
